These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28079640)

  • 21. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes.
    Gupta N; Weitzman RE; Murad F; Koyfman SA; Smile TD; Chang MS; Maher JM; Schmults CD; Vidimos AT; Ruiz ES
    J Am Acad Dermatol; 2022 Jun; 86(6):1301-1308. PubMed ID: 34864111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management.
    Ruiz ES; Karia PS; Morgan FC; Schmults CD
    J Am Acad Dermatol; 2017 Feb; 76(2):217-225. PubMed ID: 27707594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Clark JR; Rumcheva P; Veness MJ
    Ann Surg Oncol; 2012 Dec; 19(13):4252-8. PubMed ID: 22805870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.
    Kus KJB; Murad F; Smile TD; Chang M; Ashrafzadeh S; Zhou G; Ilori EO; Koyfman SA; Vidimos AT; Schmults CD; Ruiz ES
    J Am Acad Dermatol; 2022 Apr; 86(4):766-773. PubMed ID: 34774657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
    Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
    J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
    Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
    J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma using the Brigham and Women's staging system: a cost analysis.
    Quinn PL; Kim JK; Prasath V; Panse N; Knackstedt TJ; Chokshi RJ
    Arch Dermatol Res; 2023 Apr; 315(3):371-378. PubMed ID: 35303163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.
    Xu S; Sagiv O; Rubin ML; Sa HS; Tetzlaff MT; Nagarajan P; Ning J; Esmaeli B
    JAMA Ophthalmol; 2019 May; 137(5):537-542. PubMed ID: 30869769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck.
    Moeckelmann N; Ebrahimi A; Dirven R; Liu J; Low TH; Gupta R; Ashford B; Ch'ng S; Palme CE; Clark JR
    Ann Surg Oncol; 2018 Jun; 25(6):1730-1736. PubMed ID: 29352431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel Lymph Node Biopsy in High-Risk Cutaneous Squamous Cell Carcinoma: Analysis of a Large Size Retrospective Series.
    Tremblay-Abel V; Poulin MA; Blouin MM; Parent F; Perron É
    Dermatol Surg; 2021 Jul; 47(7):908-913. PubMed ID: 33988549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management.
    Farberg AS; Hall MA; Douglas L; Covington KR; Kurley SJ; Cook RW; Dinehart SM
    Curr Med Res Opin; 2020 Aug; 36(8):1301-1307. PubMed ID: 32351136
    [No Abstract]   [Full Text] [Related]  

  • 34. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.
    Xu MJ; Lazar AA; Garsa AA; Arron ST; Ryan WR; El-Sayed IH; George JR; Algazi AP; Heaton CM; Ha PK; Yom SS
    Head Neck; 2018 Jul; 40(7):1406-1414. PubMed ID: 29524273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
    Spolverato G; Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2017 May; 115(6):696-703. PubMed ID: 28194791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging.
    Mao YP; Xie FY; Liu LZ; Sun Y; Li L; Tang LL; Liao XB; Xu HY; Chen L; Lai SZ; Lin AH; Liu MZ; Ma J
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1326-34. PubMed ID: 19153016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma.
    Pérez-Baena MJ; Mao JH; Pérez-Losada J; Santos-Briz Á; Chang H; Cañueto J
    Clin Exp Dermatol; 2024 Jun; 49(7):692-698. PubMed ID: 37572359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging System Performance and Clinical Outcomes for Cutaneous Squamous Cell Carcinoma of the Ear: A Single-Center Retrospective Study.
    Navarrete-Dechent C; Mori S; Connolly K; Shah K; Dusza SW; Rossi AM; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2023 Aug; 49(8):747-754. PubMed ID: 37235869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
    Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
    JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Mohs Micrographic Surgery on Tumor Staging of Cutaneous Squamous Cell Carcinoma: A Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Guidelines.
    Montuno MA; Brown B; Konda S; Motaparthi K
    Dermatol Surg; 2018 Aug; 44(8):1057-1064. PubMed ID: 29746431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.